Recurrent Ph-Like Acute Lymphoblastic Leukemia
2 clinical trials · Condition
◉ Watch Recurrent Ph-Like Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| CD19-Specific T Cells Post AlloSCT (NCT03579888) | M.D. Anderson Cancer Center | 2020-06-26 |
| Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (NCT02420717) | M.D. Anderson Cancer Center | 2015-07-15 |
Track Recurrent Ph-Like Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.